+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
From
Cancer Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Immunotherapy - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
Sarcoma Drugs - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
Orphan Drugs Market Report 2023-2033 - Product Thumbnail Image

Orphan Drugs Market Report 2023-2033

  • Report
  • October 2023
  • 258 Pages
  • Global
From
Metastatic Bone Disease - Global Strategic Business Report - Product Thumbnail Image

Metastatic Bone Disease - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
Immunotherapy Drugs - Global Strategic Business Report - Product Thumbnail Image

Immunotherapy Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 193 Pages
  • Global
From
From
Dermatological Drugs Market 2025-2033 - Product Thumbnail Image

Dermatological Drugs Market 2025-2033

  • Report
  • March 2025
  • 138 Pages
  • Global
From
From
Peptide Therapeutics Market 2024-2028 - Product Thumbnail Image

Peptide Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 148 Pages
  • Global
From
From
From
Protein Therapeutics Market 2024-2028 - Product Thumbnail Image

Protein Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 191 Pages
  • Global
From
Loading Indicator